Literature DB >> 8380257

Regulation of muscle transcription by the MyoD family. The heart of the matter.

E N Olson1.   

Abstract

The two striated muscle cell types, skeletal and cardiac muscle, express overlapping sets of muscle-specific genes. Activation of muscle-specific transcription in skeletal muscle is controlled by the MyoD family of regulatory factors, which are expressed exclusively in skeletal muscle. Members of the MyoD family share homology within a basic helix-loop-helix (HLH) motif that mediates DNA binding and dimerization and form heterodimers with widely expressed HLH proteins, referred to as E proteins. Although many of the genes that are regulated by members of the MyoD family are also expressed in cardiac muscle, known members of the MyoD family have never been detected in cardiac muscle, suggesting that cardiac myocytes either express unique cell type-specific HLH proteins or rely on a distinct regulatory strategy for activation of cardiac muscle transcription. This review will summarize current knowledge of the mechanisms through which the MyoD family activates skeletal muscle transcription and will consider potential mechanisms that may regulate gene expression in the heart.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380257     DOI: 10.1161/01.res.72.1.1

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.

Authors:  T H Christensen; L Kedes
Journal:  Gene Expr       Date:  1999

2.  Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.

Authors:  A Weiss; D McDonough; B Wertman; L Acakpo-Satchivi; K Montgomery; R Kucherlapati; L Leinwand; K Krauter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase.

Authors:  Alison M O'Mahony; Donal A Walsh
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 4.  The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers.

Authors:  David Liberg; Mikael Sigvardsson; Peter Akerblad
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

Review 5.  Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation.

Authors:  Anthony B Firulli; Simon J Conway
Journal:  Birth Defects Res C Embryo Today       Date:  2004-06

6.  Differential effects of hypoxic and hyperoxic stress-induced hypertrophy in cultured chick fetal cardiac myocytes.

Authors:  Allison A Greco; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-29       Impact factor: 2.416

7.  Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities.

Authors:  Beth A Firulli; Dayana Krawchuk; Victoria E Centonze; Neil Vargesson; David M Virshup; Simon J Conway; Peter Cserjesi; Ed Laufer; Anthony B Firulli
Journal:  Nat Genet       Date:  2005-02-27       Impact factor: 38.330

8.  Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice.

Authors:  D B Donoviel; M A Shield; J N Buskin; H S Haugen; C H Clegg; S D Hauschka
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

9.  Motif discovery in tissue-specific regulatory sequences using directed information.

Authors:  Arvind Rao; Alfred O Hero; David J States; James Douglas Engel
Journal:  EURASIP J Bioinform Syst Biol       Date:  2007

10.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.

Authors:  P Rosenkranz-Weiss; W C Sessa; S Milstien; S Kaufman; C A Watson; J S Pober
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.